Overview

VIGABatrin in Post-anoxic STATus Epilepticus - Phase IIa

Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This is a pilot trial of a single loading dose of vigabatrin in post-anoxic status epilepticus.
Phase:
Phase 2
Details
Lead Sponsor:
University of Florida
Collaborators:
Thomas Jefferson University
Yale University
Treatments:
Vigabatrin